Exosome-derived miR-25-3p and miR-92a-3p stimulate liposarcoma progression

Despite the development of combined modality treatments against liposarcoma (LPS) in recent years, a significant proportion of patients respond only modestly to such approaches, possibly contributing to local or distant recurrence. Early detection of recurrent or metastatic disease could improve pat...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Cancer Res
Päätekijät: Casadei, Lucia, Calore, Federica, Creighton, Chad J., Guescini, Michele, Batte, Kara, Iwenofu, O. Hans, Zewdu, Abeba, Braggio, Danielle A., Lynn Bill, Kate, Fadda, Paolo, Lovat, Francesca, Lopez, Gonzalo, Gasparini, Pierluigi, Chen, James L., Kladney, Raleigh D., Leone, Gustavo, Lev, Dina, Croce, Carlo M., Pollock, Raphael E.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2017
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6033276/
https://ncbi.nlm.nih.gov/pubmed/28588009
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-16-2984
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia